局限性前列腺癌根治术后个体化肿瘤学监测
该回顾性人群研究纳入11,552例根治性前列腺切除术患者,基于生化复发风险与竞争性死亡风险构建风险适应随访模型。结果显示不良病理特征患者需初期密集随访后降级,有利特征患者每9个月随访即可,且随访应个体化。
要点
- 不良病理特征患者术后前2年每3月、至6年每半年随访,之后降级。
- 有利特征患者每9个月随访足够。
- 随访策略应基于复发风险与竞争性死亡风险个体化制定。
核心结论
- 根治性前列腺切除术后监测方案应个体化,随访强度和时长基于生化复发风险与竞争性死亡风险。
研究设计与样本
- 回顾性人群研究,纳入11,552例接受根治性前列腺切除术的患者。
主要发现
- 8,662例(75%)患者具有不良病理特征(pT3-4、pN1、切缘阳性、和/或ISUP>2)。
- 无复发患者中位随访90个月。
- 5年生化复发无生存率、EAU高危生化复发无生存率、EMBARK高危生化复发无生存率分别为78%、91%、98%。
- 不良特征患者需前几年密集随访(前2年每季度,至6年每半年),之后降级。
- 有利特征患者每9个月随访足够;高危生化复发模式类似但密集期较短(至3年)。
关键数值与推荐
- 生化复发风险低于竞争性死亡风险的随访年份范围:生化复发为4-20+年,EAU高危生化复发为1-12年,EMBARK高危生化复发为1-4年,取决于疾病特征、年龄和合并症。
临床怎么用
- 根据个体复发风险和竞争性死亡风险制定术后随访强度和时长,不良特征患者初期密集后降级,有利特征患者可延长随访间隔。
局限性
- 本研究为回顾性设计,所提策略需未来研究验证后方可临床实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The oncologic surveillance after radical prostatectomy (RP) remains poorly defined. OBJECTIVE: To evaluate a model-derived, risk-adapted surveillance approach and estimate when the modeled OCM hazard exceeds the modeled recurrence hazard. DESIGN, SETTING, AND PARTICIPANTS: Retrospective, population-based study including 11,552 patients undergoing RP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We developed a follow-up schedule based on the per-visit risk of biochemical recurrence (BCR) and high-risk BCR (HR-BCR), according to the EAU and EMBARK criteria, optimizing the number of PSA tests while maintaining the detection rate of the EAU schedule. Weibull regression was used to estimate model-derived time points at which OCM hazard exceeded recurrence hazard. RESULTS AND LIMITATIONS: Overall, 8,662 (75%) patients had adverse pathological features (pT3-4, pN1, positive surgical margins, and/or ISUP>2). Median follow-up among patients without recurrence was 90 months. The 5-year BCR-, EAU-HR-BCR-, EMBARK-HR-BCR-free survival probabilities were 78%, 91%, and 98% , respectively. Compared to the EAU schedule, adverse-feature patients required intensive follow-up in the first years (quarterly for 2 years, biannually up to 6 years), with de-intensification thereafter. Every 9 months visits were sufficient for favorable-feature patients. A similar pattern was observed for HR-BCR, but with a shorter intensive period (up to 3 years). The follow-up year when the hazard of BCR, EAU-HR-BCR, and EMBARK-HR-BCR became lower than the hazard of OCM ranged from 4-20+, 1-12, and 1-4 years, depending on disease characteristics, age, and comorbidity. CONCLUSIONS: Our results show that surveillance protocols should be individualized. We presented a post-RP surveillance strategy in which the intensity and duration of follow-up are based on the risk of BCR and OCM according to individual recurrence risk and competing mortality. Future studies are needed to validate this strategy before it can be implemented in clinical practice.
引用
- Pellegrino F, Falagario UG, Abbadi A, et al. Individualized Oncologic Surveillance After Radical Prostatectomy for Localized Prostate Cancer. Eur Urol Oncol. 2026. PMID: 42791144. doi:10.1016/j.euo.2026.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。